| apoCIII | Apolipoprotein CIII |
| BB | Biobreeding rat |
| C/EBPδ/NF-IL6-β | CAAT enhancer-binding protein δ/nuclear factor/IL6- β |
| CVD | Cardiovascular disease |
| CaV | Voltage-gated Ca2+-channels |
| ChREBP | Carbohydrate response element–binding protein |
| DAMPs | Danger-associated molecular patterns |
| DPBB | Diabetes-prone BB rat |
| EC | Endothelial cells |
| ERK1/2 | Extracellular signal-regulated kinases 1/2 |
| Foxo1 | Forkhead box O1 |
| G-banding | Giemsa-banding |
| HDL | High-density lipoprotein |
| HNF-4α | Hepatocyte nuclear receptor-4α |
| HLA | Human leukocyte antigens |
| ICAM-1 | Intracellular adhesion molecule |
| IL | Interleukin |
| IDL | Intermediate-density lipoproteins |
| IRE | Insulin/phorbol ester responsive element |
| IκΒ | Inhibitor of κΒ |
| LDL | Low-density lipoprotein |
| LDLR | LDL receptor |
| LPL | Lipoprotein lipase |
| LRP1 | LDL-related protein 1 |
| LXR | Liver X receptors |
| MAPK | Mitogen activated protein kinase |
| NF-κB | Nuclear factor kappa-B |
| NLRP3 | Nod-like pyrin domain-containing 3 |
| PAMPs | Pathogen-associated molecular patterns |
| PK | Pyruvate kinase |
| PKA | Protein kinase A |
| PKCα | Protein kinase C α |
| SCIMP | SLP adaptor and CSK-interacting membrane protein |
| SLE | Systemic lupus erythematosus |
| SR-BI | Scavenger-receptor class BI |
| Src | Proto-oncogene tyrosine-protein kinase Src |
| T1D | Type-1 diabetes |
| T2D | Type-2 diabetes |
| TEDDY | The Environmental Determinants of Diabetes in the Young |
| Tgs | Triglycerides |
| TNF-α | Tumor necrosis factor α |
| TRL | Triglyceride-rich lipoprotein |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VLDL | Very low-density lipoproteins |
| [Ca2+]i | Cytoplasmic-free Ca2+ concentration |